As a rare animal traditional Chinese medicine,Tubiechong(Eupolyphaga Steleophaga)has been commonly used in clinical practice,which is the essentialmedicine of ancient doctors to promote blood circulation and treat injury. It has the effect of breaking blood and removing blood stasis,and reinforcing tendons and setting bones. The processing of Tubiechong(Eupolyphaga Steleophaga)has a long history,and it was recorded as early as in the Han Dynasty. There were more than 10 processing methods,such as stir-frying,baking,lime and so on after Han Dynasty. Tubiechong(Eupolyphaga Steleophaga)hasmild toxicity. After processing,it can reduce toxicity,correctodor and flavor,facilitate pulverization and clinicalapplication. Modern studies have shown that the main chemical components of Tubiechong(Eupolyphaga Steleophaga)include protein polypeptides,nucleosides,fatty acids,phenylpropanoids,alkaloids and other compounds,which have anti-coagulant,anti-thrombotic,anti-tumor and analgesia effects and so on. This paper reviewed the processing history evolution,chemical constituents and pharmacological effects of Tubiechong(Eupolyphaga Steleophaga)by referring to herbs,medical books and related literature in the past dynasties,in order to lay a foundation for the clinical rational drug use of Tubiechong(Eupolyphaga Steleophaga)of different processing specifications,the improvement of the standards of decoction pieces and the functional core substances and other related research.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |